Skip to content

Sarepta Therapeutics, Inc. SRPT Business Segments — Facility And Technology Related Expenses

Similar metrics at other companies

QCR Holdings logo
QCRHAll Other Segments — Equipment Expense
$895K+84.5%
Imax logo
IMAXTechnology Products and Services Segment — Other segment expenses
$15.12M-1.9%
Madrigal Pharmaceuticals, Inc. logo
MDGLReportable Segment — Facility And Other Expenses
$27.61M+74.9%
Bicara Therapeutics logo
BCAXReportable Segment — Facility costs, IT, office expense and other
$1.22M+8.9%
ePlus logo
PLUSAll Other Segments — Total Costs & Expenses
$43K-39.4%
QCR Holdings logo
QCRHAll Other Segments — Labor And Related Expense
$1.22M+70.3%

Other financials

Income statement

See full
Revenue$730.8M-1.9%
Operating income-$300.4M-961%
Net income$331.0M+174%
EPS (diluted)-$4.60-1,343%

Balance sheet

See full
Cash & equivalents$464.5M+92.8%
Total debt$198.5M-3.4%
Total equity$1.5B+31.7%
Total assets$3.2B-8.3%

Cash flow

See full
Operating cash flow-$202.7M+65.3%
CapEx$2.1M-95.2%
Free cash flow-$204.8M+67.3%

Valuation

See full
Market cap$1.82B-63.1%
Enterprise value$1.56B-67.2%
P/S0.8×

Profitability

See full
Operating margin-50.8%-1.6pp
Net margin4.6%+2.4pp
FCF margin-28.7%-9.2pp

Returns & leverage

See full
Return on equity-23.6%-28.5pp
Debt / equity0.1×0.0×
Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept srpt:FacilityAndTechnologyRelatedExpenses.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s business segments — facility and technology related expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s business segments — facility and technology related expenses?
Sarepta Therapeutics, Inc. (SRPT) reported business segments — facility and technology related expenses of $22.94M in Q1 2026.
How has Sarepta Therapeutics, Inc.'s business segments — facility and technology related expenses changed year-over-year?
Sarepta Therapeutics, Inc.'s business segments — facility and technology related expenses decreased by 17.0% year-over-year, from $27.66M to $22.94M.
What is the long-term trend for Sarepta Therapeutics, Inc.'s business segments — facility and technology related expenses?
Over 3 years (2022 to 2025), Sarepta Therapeutics, Inc.'s business segments — facility and technology related expenses has grown at a 14.1% compound annual growth rate (CAGR), from $71.7M to $106.46M.
What does business segments — facility and technology related expenses mean?
Covers the overhead costs associated with maintaining physical facilities and the technological infrastructure required to support segment operations. This metric highlights the fixed cost burden and digital investment levels of the business unit.